NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024Business Wire • 08/01/24
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionBusiness Wire • 07/29/24
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingBusiness Wire • 07/26/24
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime DayBusiness Wire • 07/16/24
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionBusiness Wire • 07/11/24
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsBusiness Wire • 06/28/24
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate UpdatesBusiness Wire • 05/29/24
NovaBay Pharmaceuticals (NBY) Shows Fast-paced Momentum But Is Still a Bargain StockZacks Investment Research • 05/21/24
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsBusiness Wire • 05/13/24
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonBusiness Wire • 05/07/24
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024Business Wire • 05/03/24
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesBusiness Wire • 04/22/24
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityBusiness Wire • 04/19/24
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesBusiness Wire • 04/17/24
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsBusiness Wire • 03/26/24
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024Business Wire • 03/25/24